New CEO Tobin, Three Approvals Signal Smoother Times For Boston Scientific

Boston Scientific used the opportunity of its annual March meeting with analysts to announce the selection of James Tobin as the next CEO, a move aimed at allaying the financial community's ongoing concerns about the firm's management and direction.

More from Archive

More from Medtech Insight